SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-002053
Filing Date
2021-01-06
Accepted
2021-01-06 16:22:26
Documents
2
Period of Report
2021-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 11521
2 EX-24 DOCUMENT attachment1.htm EX-24 3392
  Complete submission text file 0001209191-21-002053.txt   16305
Mailing Address C/O SANGAMO BIOSCIENCES, INC STE-A-100 POINT RICHMOND TECH, 501 CANAL BLVD, RICHMOND CA 94804
Business Address
ZANTE GREG (Reporting) CIK: 0001264949 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37355 | Film No.: 21510854

Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Issuer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations